eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | 22q11.2 deletion syndrome |
| Comorbidity | C0679466|cognitive deficits |
| Sentences | 3 |
| PubMedID- 22763378 | Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. |
| PubMedID- 19962860 | Chromosome 22q11.2 deletion syndrome (22q11ds) is associated with cognitive deficits and morphometric brain abnormalities in childhood and a markedly elevated risk of schizophrenia in adolescence/early adulthood. |
| PubMedID- 22678699 | The goal of this trial was to assess the feasibility and safety of using s-adenosyl-l-methionine (same) to treat depressive disorder, attention deficit/hyperactivity disorder (adhd) and cognitive deficits in individuals with the 22q11.2 deletion syndrome (22q11.2ds). |
Page: 1